Literature DB >> 19138733

SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.

Chang-Moon Lee1, Hwan-Jeong Jeong, Se-Lim Kim, Eun-Mi Kim, Dong Wook Kim, Seok Tae Lim, Kyu Yoon Jang, Yong Yeon Jeong, Jae-Woon Nah, Myung-Hee Sohn.   

Abstract

The aim of this study was to develop a novel polymeric magnetic nanoprobe as an MRI contrast agent to target hepatocytes, as well as to evaluate the targeting ability of the nanoprobe with MRI in vivo. Superparamagnetic iron oxide nanocrystals (SPIONs) were synthesized by a thermal decomposition and seed growth method. An 1-ethyl-3-(3-(dimethylamino)-propyl) carbodiimide (EDC)-mediated reaction coupled water-soluble chitosan (WSC) to linoleic acid (LA). Twelve-nanometer-sized SPIONs were incorporated into the core of self-assembled WSC-LA nanoparticles. The morphology and size distribution of the SPION-loaded WSC-LA nanoparticles (SCLNs) were determined by transmittance electron microscopy (TEM) and dynamic light scattering (DLS), respectively. The encapsulation of SPIONs in the WSC-LA nanoparticles reduced the cytotoxicity of bare iron particles and enhanced their dispersion ability in water. The clustering of SPIONs into WSC-LA nanoparticles showed ultrasensitive magnetic behavior. After in vivo intravascular SCLN injection, MRI revealed relative signal enhancement in the liver. The localization of SCLN in hepatocytes was confirmed by Prussian blue staining and TEM analysis. We have successfully developed an ultrasensitive SCLN that effectively targets hepatocytes. The SCLN can be used as a contrast agent to aid in the diagnosis of hepatic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19138733     DOI: 10.1016/j.ijpharm.2008.12.021

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin.

Authors:  Chang-Moon Lee; Hwan-Jeong Jeong; Su-Jin Cheong; Eun-Mi Kim; Dong Wook Kim; Seok Tae Lim; Myung-Hee Sohn
Journal:  Pharm Res       Date:  2010-02-25       Impact factor: 4.200

2.  Glycol-Chitosan-Based Technetium-99m-Loaded Multifunctional Nanomicelles: Synthesis, Evaluation, and In Vivo Biodistribution.

Authors:  Nashmia Zia; Zafar Iqbal; Abida Raza; Aadarash Zia; Rabia Shafique; Saiqa Andleeb; Gilbert C Walker
Journal:  Nanomaterials (Basel)       Date:  2022-06-27       Impact factor: 5.719

3.  Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer.

Authors:  Yinan Ding; Rui Yang; Weiping Yu; Chunmei Hu; Zhiyuan Zhang; Dongfang Liu; Yanli An; Xihui Wang; Chen He; Peidang Liu; Qiusha Tang; Daozhen Chen
Journal:  J Nanobiotechnology       Date:  2021-05-19       Impact factor: 10.435

4.  Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy.

Authors:  Eun-Kyung Lim; Warayuth Sajomsang; Yuna Choi; Eunji Jang; Hwunjae Lee; Byunghoon Kang; Eunjung Kim; Seungjoo Haam; Jin-Suck Suh; Sang Jeon Chung; Yong-Min Huh
Journal:  Nanoscale Res Lett       Date:  2013-11-08       Impact factor: 4.703

5.  High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging.

Authors:  Yunbin Xiao; Zuan Tao Lin; Yanmei Chen; He Wang; Ya Li Deng; D Elizabeth Le; Jianguo Bin; Meiyu Li; Yulin Liao; Yili Liu; Gangbiao Jiang; Jianping Bin
Journal:  Int J Nanomedicine       Date:  2015-02-05

Review 6.  Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.

Authors:  Jaehong Key; Kyeongsoon Park
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

7.  SPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agent.

Authors:  Xiuliang Zhu; Xueying Deng; Chenying Lu; Ying Chen; Liyong Jie; Qian Zhang; Wei Li; Zuhua Wang; Yongzhong Du; Risheng Yu
Journal:  Quant Imaging Med Surg       Date:  2018-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.